Klaria Pharma Holding AB Logo

Klaria Pharma Holding AB

Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.

KLAR | ST

Overview

Corporate Details

ISIN(s):
SE0007280326
LEI:
529900YLMSNHNP7HOD11
Country:
Sweden
Address:
Virdings Allé 2, 754 50 UPPSALA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Klaria Pharma Holding AB is a pharmaceutical company that develops novel drug products based on its patented, proprietary alginate-based oral transmucosal film technology. This platform delivers active pharmaceutical ingredients directly into the bloodstream by adhering to the inside of the cheek, providing a non-invasive alternative to treatments currently available only as injections or nasal sprays. The company's strategy focuses on addressing significant patient needs where its technology offers clear advantages, such as improved convenience, safety, and efficacy. Klaria's development pipeline includes treatments for migraine (Sumatriptan), severe allergic reactions (Epinephrine), and organ transplant rejection (Sirolimus). The company also operates a subsidiary, Cannabis Delivery Sciences, which applies the film technology to cannabinoid-based products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Klaria Pharma Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Klaria Pharma Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PEPTONIC Medical AB Logo
Develops clinically proven self-care products for women's intimate health.
Sweden PMED
Develops sustained-release peptide medicines for chronic & neurodegenerative disorders.
South Korea 087010
Perseus Proteomics Inc. Logo
Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.
Japan 4882
PharmAbcine Inc. Logo
Develops antibody therapies for cancer, eye diseases, and vascular-related disorders.
South Korea 208340
Pharma Foods International Co., Ltd. Logo
Researches and sells functional ingredients and direct-to-consumer health & beauty products.
Japan 2929
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain PHM
Pharmanutra Logo
Researches and markets nutritional supplements & medical devices for all ages.
Italy PHN
PHARMARESEARCH BIO Co., Ltd. Logo
A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.
South Korea 217950
PharmaResearch Co., Ltd. Logo
Develops regenerative medicine, devices & cosmetics using marine biotechnology.
South Korea 214450
PharmaSGP Holding SE Logo
Develops and markets leading natural OTC drugs for chronic conditions in the European market.
Germany PSG

Talk to a Data Expert

Have a question? We'll get back to you promptly.